Purchase or produce a medicated drug for overweight or obesity using sustained release of Namtresser or one of its salts and sustained release of one of its salts.

• 收藏
• 分享

专利权人:

OREXIGEN THERAPEUTICS; INC

发明人:

KLASSEN, PRESTON,TAYLOR, KRISTIN

申请号：

CL2014003329

公开号：

CL2014003329A1

申请日:

2014.12.05

申请国别(地区):

CL

年份:

2015

代理人:

摘要：

The present disclosure relates to compositions, kits, uses, systems and methods for treating overweight and obesity using naltrexone plus bupropion, preferably in combination with a comprehensive web-based and/or telephone-based weight management program, and preferably in subjects at increased risk of adverse cardiovascular outcomes.USO DE NALTREXONA DE LIBERACIÓN SOSTENIDA O UNA DE SUS SALES Y BUPROPIÓN DE LIBERACIÓN SOSTENIDA O UNA DE SUS SALES PARA PREPARAR UN MEDICAMENTO ÚTIL PARA EL TRATAMIENTO DE SOBREPESO U OBESIDAD.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/